Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

Published:2021-12 Issue:6 Volume:6 Page:100299
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Müller V.,Banys-Paluchowski M.,Friedl T.W.P.,Fasching P.A.,Schneeweiss A.,Hartkopf A.,Wallwiener D.,Rack B.,Meier-Stiegen F.,Huober J.,Rübner M.,Hoffmann O.,Müller L.,Janni W.,Wimberger P.,Jäger B.,Pantel K.,Riethdorf S.,Harbeck N.,Fehm T.

Funder

Roche

Pfizer

Deutsche Krebshilfe

Celgene

AstraZeneca

AbbVie

Meso Scale Diagnostics

Eli Lilly and Company

Daiichi-Sankyo

Novartis

Eisai

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): international expert consensus paper;Cristofanilli;Crit Rev Oncol Hematol,2019

2. Circulating tumor cells in metastatic breast cancer: clinical applications and future possibilities;Banys-Paluchowski;Appl Sci,2020

3. HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy;Santinelli;Int J Cancer,2008

4. Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer;Ligthart;Ann Oncol,2013

5. Receptor conversion in distant breast cancer metastases: a systematic review and meta-analysis;Schrijver;J Natl Cancer Inst,2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors;Critical Reviews in Oncology/Hematology;2024-11

2. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment;Bioorganic Chemistry;2024-10

3. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

4. Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine;Current Opinion in Oncology;2024-07-16

5. Rapid Isolation and Detection of Breast Cancer Circulating Tumor Cells Using Microfluidic Sequential Trapping Array;Advanced Sensor Research;2024-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3